B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site
- B.Braun Medical, Inc.
BETHLEHEM, Pa., Jan. 28, 2022 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical manufacturing plant in Daytona Beach, FL. The site will produce 0.9% Sodium Chloride for Injection available in B. Braun’s Excel® Plus IV Bags in 1,000 mL and 500 mL sizes. Consistent with B. Braun’s decades-long commitment to protect patients from exposure to harmful chemicals, the Excel Plus IV bags are not made with PVC, DEHP or natural rubber latex. Read more…
Related Reading
Event / Regulatory Affairs
Reducing Regulatory Burden and Streamlining FDA Review Through ASCA Pilot Program Utilization
July 20, 2022
10:00 AM
Join NAMSA and the FDA as they present a webinar on the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program, a first-of-its-kind conformity assessment program created by the U.S. FDA.
News / Global & Trade
AdvaMed Welcomes Progress for Medtech Patients at Summit of the Americas
June 14, 2022
The Advanced Medical Technology Association, AdvaMed, today welcomed several outcomes of the just-concluded IX Summit of the Americas in Los Angeles.
Blog / Global & Trade
Why Patients Deserve Priority in Global Semiconductor Chips Shortage
June 6, 2022
Frans van Houten, CEO of Royal Philips, explains the potentially dire consequences of unchecked chip shortages for monitoring unborn babies, treating sudden cardiac arrest patients, assessing the vital signs of intensive care patients, and more.
Global & Trade
AdvaMed’s China Presence
AdvaMed’s office in China sits at the forefront of helping our members navigate China’s large, fast-growing market for medical technologies.
News / Global & Trade
AdvaMed, Member Company Executives Meet with Semiconductor Industry, Department of Commerce Officials on Chips to Ensure Patient Care Comes First
May 26, 2022
Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed), the largest global trade organization representing the medical technology sector, joined a meeting with Deputy Secretary of Commerce Don Graves and members of his Commerce Department team, the Food and Drug Administration supply chain resiliency team, medtech supply chain executives, and semiconductor industry executives to discuss the needs of the health care industry amidst pervasive chips shortages.
News / Global & Trade
AdvaMed Joins Biden Administration Working Group to Address Medtech Supply Chain Concerns That Could Soon Affect Patient Care
May 19, 2022
The Advanced Medical Technology Association (AdvaMed), the world’s largest trade organization representing medical technology manufacturers, announced its new role in the Biden Administration’s Joint Supply Chain Resilience Working Group.
Blog / Global & Trade
AdvaMed Resources for Ukraine Humanitarian Needs
May 12, 2022
AdvaMed is collaborating with the U.S. and Ukrainian governments to facilitate donations of urgently needed medical supplies to Ukraine.
News / Global & Trade / Government Affairs & Legislative
AdvaMed, Medtech Leaders, Commerce Secretary Raimondo Discuss Impact of Semiconductor Chip Shortage on Patient Care
May 3, 2022
Scott Whitaker, President and CEO of AdvaMed, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the industry.